K

Krsnaa

(NSE: KRSNAA)

KRSNAA

491.15

0.00 (0.00%)

Krsnaa Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Krsnaa Price Chart

Note: The data used to display charts is delayed by 15 mins as per guidelines.

Krsnaa Price Summary

Today’s High

504.95

Today’s Low

488.2

52 Week's High

504.95

52 Week's Low

488.2

Krsnaa Fundamentals

Market Cap

1865.5 Cr

CASA

NA

No. Of Shares

3.1 Cr

P/E

0.0

P/B

0.0

Face Value

5.0

Dividend Yeild

NA

Book Value

-17.5

Net Interest Income

122.3

Cost to Income

NA

Promoter Holdings

27.4

EPS

284.7

CAR

NA

ROE

0.0

ROCE

129.1

Profit Growth

NA

Krsnaa Peer Comparison

COMPANY

PRICE

MCAP (cr)

P/B

P/E

EPS

ROE

ROCE

NII

Krsnaa

491.15

1865.5 Cr

0.0

0.0

284.7

0.0

129.1

122.3

Unichem Laboratories

390.6

1874.6 Cr

0.8

40.3

7.7

2.0

2.5

2.3K

Solara Active Pharma

450.45

1841.4 Cr

3.2

22.7

61.5

17.1

15.3

14.4

Kovai Medical

1513.75

1791.7 Cr

2.4

15.5

71.0

16.5

13.7

765.8

Alembic

67.05

1730.7 Cr

3.2

197.6

0.5

2.0

2.6

83.3

Neuland Labs

1381.25

1696.9 Cr

3.4

33.4

62.6

10.8

12.8

166.7

FAQ’s on Krsnaa

About Krsnaa

Krsnaa Diagnostics is one of the largest differentiated diagnostic service provider in India. It provides a range of technology-enabled diagnostic services such as imaging (including radiology), pathology/clinical laboratory and tele-radiology services to public and private hospitals, medical colleges and community health centres pan-India. It also operate one of India’s largest tele-radiology reporting hubs in Pune that is able to process large volumes of X-rays, CT scans and MRI scans round the clock and 365 days a year, and allows it to serve patients in remote locations where diagnostic facilities are limited. It provides quality and inclusive diagnostic services at affordable rates across various segments.

The company offers range of diagnostics imaging services and clinical laboratory tests that include both routine and specialized tests / studies and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Its diagnostic imaging/radiology services include conducting X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, ultrasounds, bone mineral densitometry and mammography. In its pathology segment, its primary focus includes biochemistry, haematology, clinical pathology, histopathology and cytopathology, microbiology, serology and immunology. A suite of diagnostic equipment is located at its tele-radiology hub along with a team of radiologists which provide it significant operating efficiencies and scalability.

Business area of the company

Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India. The company offers a wide range of diagnostic services such as imaging/radiology services (X-rays, MRI, etc.), routine clinical laboratory tests, pathology, and tele-radiology services to private and public hospitals, medical colleges, and community health centres.

Key awards, accreditations or recognitions

  • 2016: Star of Asia Award for Health Excellence at the 10th International Seminar of the Indian Achievers Forum.
  • 2017: Emerging Company Award for Health Excellence at the 42nd National Seminar of the Indian Achiever’s Awards.
  • 2019: India’s Greatest Brands Award for Healthcare and Diagnostics by Asia One.
  • 2020: Best Diagnostic and Imaging Centre of the Year (Asia) at the Asia Healthcare Summit and Awards.
  • 2020: Best Diagnostics Service Company of the Year at the India Excellence Awards by ET Now.
  • 2020: Outstanding Achievement Award in Healthcare Social Causes at the India Excellence Awards by ET Now.

Major events and milestones

  • 2011: Incorporation of the company with two radiology centres.
  • 2013: Started operating 12 centres in Himachal Pradesh in public private partnership.
  • 2016: Investment by Somerset and Kitara in the Company.
  • 2017: Completed installation of 50 centres in four states.
  • 2018: Expanded operations across 13 states.
  • 2019: Received accreditation from NABH for a centre in Madhya Pradesh.
  • 2019: Investment by Phi Capital in the company.
  • 2020 Received accreditation from NABH and NABL for certain centres in Maharashtra.
  • 2020: Expanded to over 1,500 centres across India.
  • 2020: Received accreditation from NABL for certain centres in Rajasthan.

Trade Krsnaa today

Create a free portfolio in Trinkerr and earn and grow along with peers